ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,282Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1844

$1.39M Total Retail Price of All Prescriptions

Rank: 15 out of 1844

564 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 564 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 564 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 17,154 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,078 718 S3 1 2
OMEPRAZOLE 803 581 2 5
SIMVASTATIN 753 613 3 3
FUROSEMIDE 737 591 4 7
LEVOTHYROXINE SODIUM 689 461 5 1
LISINOPRIL 602 464 6 4
AMLODIPINE BESYLATE 560 470 7 6
WARFARIN SODIUM 485 436 8 13
GABAPENTIN 472 339 9 15
CITALOPRAM HBR 428 325 10 19
POTASSIUM CHLORIDE 427 314 11 16
CARVEDILOL 345 304 12 22
GLIMEPIRIDE 289 213 13 35
METOPROLOL SUCCINATE 277 201 14 14
ZOLPIDEM TARTRATE 269 157 15 23
METOPROLOL TARTRATE 235 214 16 11
TRAMADOL HCL 232 160 17 18
LANTUS 220 123 18 42
PRAVASTATIN SODIUM 218 140 19 10
HYDROCHLOROTHIAZIDE 217 191 20 9
LOSARTAN POTASSIUM 217 185 20 24
NAMENDA 214 211 22 33
ATORVASTATIN CALCIUM 214 149 22 12
CYMBALTA 210 87 24 36
NYSTATIN 209 187 25 85
CYCLOBENZAPRINE HCL 206 114 R 26 53
NOVOLOG 194 136 27 84
ATENOLOL 179 133 28 17
MIRTAZAPINE 178 127 29 49
PREDNISONE 176 127 30 40
DONEPEZIL HCL 169 163 31 26
POLYETHYLENE GLYCOL 3350 164 138 32 39
DIOVAN 162 146 33 58
LYRICA 154 80 34 92
ALLOPURINOL 153 113 35 29
PROMETHAZINE HCL 149 71 R 36 88
RISPERIDONE 148 100 37 65
CEPHALEXIN 148 128 37 56
SPIRIVA 147 96 39 57
LEVETIRACETAM 146 90 40 105
METFORMIN HCL 145 76 41 8
DOXYCYCLINE HYCLATE 137 85 42 90
TRAZODONE HCL 136 62 43 43
CIPROFLOXACIN HCL 125 111 44 62
OXYCODONE-ACETAMINOPHEN 125 0 S2 44 94
FAMOTIDINE 125 109 44 63
TAMSULOSIN HCL 123 96 47 27
ISOSORBIDE MONONITRATE ER 121 102 48 59
CLOPIDOGREL 118 80 49 34
QUETIAPINE FUMARATE 117 75 50 82
HUMALOG 117 79 50 114
AMOXICILLIN 116 75 52 101
AZITHROMYCIN 112 70 53 37
JANUVIA 106 76 54 77
LIDODERM 106 65 54 155
FENTANYL 104 57 S2 56 66
BUSPIRONE HCL 99 61 57 127
PANTOPRAZOLE SODIUM 98 87 58 32
TRIAMTERENE-HCTZ 97 92 59 48
PROAIR HFA 96 43 60 45
LEVOFLOXACIN 96 70 60 78
SPIRONOLACTONE 94 62 62 60
FLUTICASONE PROPIONATE 94 49 62 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 64 62 73
ADVAIR DISKUS 94 72 62 51
VENLAFAXINE HCL 94 63 62 262
ESCITALOPRAM OXALATE 94 57 62 52
ZETIA 93 68 68 81
RANITIDINE HCL 93 44 68 38
BYSTOLIC 91 85 70 106
LEVEMIR 88 67 71 157
PLAVIX 88 60 71 61
ROPINIROLE HCL 86 63 73 76
NABUMETONE 83 72 74 158
PHENYTOIN SODIUM EXTENDED 82 43 75 147
OLANZAPINE 82 49 75 117
BACLOFEN 82 42 75 119
MORPHINE SULFATE ER 81 49 S2 78 107
OXYBUTYNIN CHLORIDE 80 47 79 103
NEXIUM 79 45 80 31
ENALAPRIL MALEATE 79 59 80 69
FLUOXETINE HCL 78 70 82 41
OXYBUTYNIN CHLORIDE ER 77 36 83 126
DIVALPROEX SODIUM 77 75 83 74
CARAFATE 74 0 85 347
SINGULAIR 73 41 86 102
VENLAFAXINE HCL ER 72 45 87 93
FENOFIBRATE 71 26 88 71
SUCRALFATE 67 43 89 183
CRESTOR 67 37 89 30
ALENDRONATE SODIUM 66 62 91 25
KLOR-CON M10 66 39 91 149
NAPROXEN 66 40 91 87
LANTUS SOLOSTAR 65 41 94 97
TORSEMIDE 64 46 95 118
DILTIAZEM 24HR CD 63 61 96 132
SYNTHROID 63 48 96 55
SERTRALINE HCL 61 48 98 21
METFORMIN HCL ER 61 47 98 46
ALBUTEROL SULFATE 60 56 100 115
DOXAZOSIN MESYLATE 60 57 100 110
LIPITOR 59 26 102 159
HYDROCORTISONE VALERATE 59 45 102 359
ABILIFY 58 0 104 150
PAROXETINE HCL 57 28 105 68
TOPIRAMATE 55 30 106 165
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 44 106 20
AMITRIPTYLINE HCL 54 29 R 108 72
DIGOXIN 53 50 109 67
DILTIAZEM HCL 52 38 110 221
GLIPIZIDE 51 45 111 70
DIOVAN HCT 51 48 111 96
OXYCONTIN 50 0 S2 113 144
CEFTRIAXONE 50 30 113 213
MELOXICAM 50 47 113 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.